Burton JH, Garrett-Mayer E, Thamm DH. Evaluation of a 15-week CHOP protocol for the treatment of canine multicentric lymphoma. Vet Comp Oncol 2013;11:306–15. Curran K, Thamm DH. Retrospective analysis for treatment of naive canine multicentric lymphoma with a 15-week, maintenance-free CHOP...
R-CHOP versus R-CVP in the treatment of follicular lymphoma: a meta-analysis and critical appraisal of current literature. J Hematol Oncol 2009; 2:14.Siddhartha G, Vijay P (2009) R-CHOP versus R-CVP in the treatment of follicular lymphoma: a meta-analysis and critical appraisal of current...
2020, Expert Review of Hematology Treatment of localized-stage follicular lymphoma 2018, European Journal of Haematology Prognostic significance of monocytes and monocytic myeloid-derived suppressor cells in diffuse large B-cell lymphoma treated with R-CHOP 2016, Cellular Physiology and BiochemistryView...
Second primary diffuse large B cell lymphoma (spDLBCL) is defined as a metachronous tumor occurring after a first primary cancer. To date, while R-CHOP is
A long-term analysis of rituximab combined with cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP) as first-line treatment was conducted in a randomised clinical trial. A six-cycle R-CHOP regimen was administered every 2 or 3 weeks without rituximab maintenance. A prespecified ...
R-CHOP(-like) treatment of diffuse large B-cell lymphoma significantly reduces CT-assessed vertebral bone density: a single center study of 111 patients 来自 Semantic Scholar 喜欢 0 阅读量: 35 作者: Pernille Svendsen,Nitesh Shekhrajka,Kasper Lindblad Nielsen,Peter Vestergaard,Tarec Christoffer ...
MR after CHOP, but not after R-CHOP, significantly prolonged time to failure but did not prolong OS. However, FFS was 42% at 9 yrs among R-CHOP responders, with or without MR. Future treatment strategies should build upon these findings in this older patient population, often with ...
R-CHOP treatment has proven to provide very effective results in limited or advanced stage of the disease. However, treatment solely involving R-CHOP submits the patient to possible chemotherapy-induced toxicities, which may be avoided with the use of radiotherapy. Patients with early stage ...
Three recent phase 1 studies have shown that lenalidomide administered on 10 to 14 days of 21-day cycle of R-CHOP could be safe in the initial treatment of aggressive or indolent B-cell lymphomas. Two of these studies determined 25 mg of lenalidomide as the recommended daily dose. This ...
Over this time, there have been several large Phase III treatment trials in which the CHOP and rituximab-CHOP (R-CHOP) regimens have been prospectively compared, including three trials confined to the elderly patient population. In these trials, it has been demonstrated repeatedly that the ...